Webb20 feb. 2024 · Conclusion: Adding atezolizumab to CP/ET as 1L treatment for ES-SCLC continued to demonstrate improved OS and a tolerable safety profile at the updated … Webb5 jan. 2024 · Abstract. For patients with metastatic non-small-cell lung cancer (mNSCLC), the last decade has been characterized by critical progress that has contributed to …
Frontiers Camrelizumab plus platinum-irinotecan followed by ...
Webb11 apr. 2024 · Oncology and Hematology PET-Adapted Treatment of Hodgkin Lymphoma Michael E. Williams, MD, ScM, reviewing LaCasce AS et al. J Clin Oncol 2024 Feb 10 … Webb0171-5216 (print) 1432-1335 (web) OCLC no. 525582786. Links. Journal homepage. Online archive. The Journal of Cancer Research and Clinical Oncology is a monthly peer … fairborn tire and battery
Volume 26, issue 1, January 2024 - SpringerLink
Webb19 apr. 2024 · Reck M, Ciuleanu T-E, Dols MC, et al: Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) … Webb7 jan. 2024 · KIM: Cemiplimab [Libtayo] has been recently approved by the FDA for treatment of advanced non–small cell lung cancer [NSCLC] with high PD-L1 expression. … WebbJournal of Clinical Oncology. Journal Abbreviation: J CLIN ONCOL. Journal ISSN: 0732-183X. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 50.717. dog shelters in chester county pa